Clinical Trial Results: Bladder Cancer

Home

Results

Protocol Registry

Trial Results

IFPMA

Background

Links

About this Registry

This database is populated with information on the results of Roche-sponsored clinical trials.

What are the differences between clinical trial phases?

Why has Roche decided to have its own registry and results database?

More FAQs

Glossary of Terms

Phase Definitions

Field Definitions

Clinical Trial Policy

Site Provided by Thomson CenterWatch

Clinical Trial Results: Bladder Cancer

Product Name: Herceptin [trastuzumab]
Date of Report: 3/15/2006
Phase: II
An open-label pilot Phase II trial of Herceptin (trastuzumab) (humanized anti-HER2 antibody) administered as monotherapy in patients with HER2-overexpressing metastatic or locally advanced Transitional Cell Carcinoma of the Bladder (TCC)


© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement

Home

Trial Results updated: November 21, 2008 at 10:39:18 AM